Hoxton Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Hoxton Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$11K	Hold	200	–	–	0.01%	245
2015 Q4	$13K	Hold	200	–	–	0.01%	218
2015 Q3	$11K	Hold	200	–	–	0.01%	228
2015 Q2	$12K	Hold	200	–	–	0.01%	230
2015 Q1	$12K	Hold	200	–	–	0.01%	218
2014 Q4	$12K	Hold	200	–	–	0.01%	220
2014 Q3	$11K	Hold	200	–	–	﹤0.01%	212
2014 Q2	$10K	Hold	200	–	–	﹤0.01%	215
2014 Q1	$11K	Buy	+200	New	+$9.24K	﹤0.01%	217

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hoxton Financial's TEVA Position: Q1 2016 in Review

Hoxton Financial held its Teva Pharmaceuticals (TEVA) position steady in Q1 2016 at 200 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #245.

Hoxton Financial first reported a position in TEVA in Q1 2014 and has held it in 9 quarters since. The position peaked at $13K in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Hoxton Financial held 200 shares of Teva Pharmaceuticals worth $11K as of Q1 2016.
Hoxton Financial left its Teva Pharmaceuticals share count unchanged in Q1 2016.
Teva Pharmaceuticals made up 0.01% of Hoxton Financial's portfolio in Q1 2016, its #245 holding.
Hoxton Financial first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
Hoxton Financial's Teva Pharmaceuticals position peaked at $13K in Q4 2015.
837 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.